research Cost-Effectiveness Analysis of Laboratory Monitoring in Newly Diagnosed Telogen Effluvium Patients
Targeted testing for telogen effluvium patients can save healthcare costs.
Search
for
Sort by
Research
690-720 / 1000+ results 
research Transgenic Erythropoietin Overexpression Inhibits Dermal Fat Formation and HIF1a in the Skin and Causes Telogen Effluvium in Mouse Pups During the First Hair Cycle
Erythropoietin overexpression disrupts hair growth and fat formation in mice.
research Post-COVID Telogen Effluvium: The Diagnostic Value of Serum Ferritin Biomarker and the Preventive Value of Dietary Supplements. A Case-Control Study
Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.
research Practical Aspects of Telogen Effluvium
Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.
research Screening of Helicobacter Pylori Infection in Patients With Telogen Effluvium
H. pylori infection may be linked to the hair shedding condition Telogen Effluvium.
research Telogen Effluvium: Tips
The document's conclusion cannot be provided because the document is not readable or understandable.
research Efficacy of Dr. SKS Hair Booster Serum for the Treatment of Hair Loss in COVID-19 Induced Persistent Telogen Effluvium
Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.
research Telogen Effluvium
Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.
research A Case of Telogen Effluvium Cured by Individualized Medicine
Individualized homeopathic treatment led to complete hair regrowth in a patient with stress-induced hair loss.
research Iron Supplementation May Improve Satisfaction in Non-Low-Ferritin Telogen Effluvium: A Real-Life Study
Iron supplements may improve hair loss satisfaction even if initial iron levels are normal.
research Homoeopathy in COVID-19 Sequelae: A Case of Telogen Effluvium
Homoeopathy has helped treat hair loss after Covid-19, considering the patient's overall condition.
research COVID-19-Associated Telogen Effluvium After Hospital Discharge: A Prospective Cohort Study
Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.
research Red LED Light Therapy for Telogen Effluvium in Long COVID Patients With and Without Androgenetic Alopecia
Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.
research Is Thyroid Dysfunction a Common Cause of Telogen Effluvium? A Retrospective Study
Hypothyroidism is often linked to the hair loss condition telogen effluvium.
research Culprits of Medication-Induced Telogen Effluvium, Part 2
Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.
research Telogen Effluvium Associated with Weight Loss: A Single Center Retrospective Study
Weight loss can cause temporary hair loss, especially in women and older adults.
research The Relationship Between Telogen Effluvium and Post-COVID-19 Infection at Klinik Sukma, January 2023-February 2023
Post-COVID-19 patients are at risk for hair loss.
research Culprits of Medication-Induced Telogen Effluvium, Part 1
Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.
research Telogen Effluvium: A 360 Degree Review
Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.
research Efficacy of Adipocyte-Derived Stem Cells-Conditioned Media in Telogen Effluvium
A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.
research Oral Vitamin D Treatment in Patients with Telogen Effluvium: Clinical and Dermoscopic Evaluation
Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.
research Review Article on Telogen Effluvium
COVID-19 survivors working in healthcare may experience temporary hair loss.
research Telogen Effluvium and COVID-19: A Cross-Sectional Study
COVID-19 infection is highly related to increased hair loss, especially in women.
research Micronutrient Deficiencies and Digital Phototrichogram Analysis in Telogen Effluvium: A Retrospective Study in a Tertiary Medical Center
Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.
research Impact of Stem Cell-Based Therapy and Platelet-Rich Plasma in Hair Loss and Telogen Effluvium Related to COVID-19
Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.
research Associations of Telogen Effluvium With Coronavirus Disease 2019 and Research Progress in Its Diagnosis and Treatment
COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.
research Serum Plasma Thiol Evaluation in Chronic Telogen Effluvium Patients
People with chronic hair shedding have lower antioxidant levels in their blood compared to healthy individuals.
research Telogen Effluvium
Telogen effluvium is a form of hair loss caused by various factors and requires identifying the cause for proper treatment.
research Efficacy and Tolerability of an Oral Supplement Containing Amino Acids, Iron, Selenium, and Marine Hydrolyzed Collagen in Subjects With Hair Loss: A Prospective, Randomized, 3-Month, Controlled, Assessor-Blinded Study
The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.
research Clinical Study on the Efficacy and Tolerability of an Oral Supplement Based on Arginine, L-Cystine, Zinc and B6 Vitamin (Cystiphane) in Patients With Telogen Effluvium
The oral supplement improved hair loss in patients with telogen effluvium.